Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • dsher
    Member
    • Feb 2013
    • 23

    FPKM=0 in cufflinks - but there are reads mapped to these genes!

    Hello everyone

    We are using BAM to map Illumina reads to a bacterial genome, followed by Cufflinks to get the FPKMs (implemented in Galaxy). We have come across many genes for which we get FPKM=0 (using both gene and transcript expression) even though there are reads mapping to these gene IDs (when we visualize using IGV).

    The genes which have"0 FPKM" have different tags: some are LOWDATA, some are HIDATA and some are OK...

    We tried changing the number of reads used as input into Cufflinks - when we used many reads (~12,000,000 on a genome with ~2,400 genes) most of the genes have 0 FPKM and "HIDATA". When we used fewer reads (1,000,000) on the same genome many of the genes still had "0 FPKM" but now with different flags (OK or LOWDATA).

    We tried using quartile normalization and this didn't seem to help much.

    Why is Cufflinks saying there is no expression from expressed genes? Can anyone suggest a reason/fix for this?

    Thanks
    Daniel
  • pbluescript
    Senior Member
    • Nov 2009
    • 224

    #2
    From the Cufflinks manual:
    --max-bundle-frags <int> Sets the maximum number of fragments a locus may have before being skipped. Skipped loci are marked with status HIDATA. Default: 1000000

    Just make that option higher. You will need to be sure the high number of reads mapping there represent reality rather than some sort of artifact though.

    Comment

    • dsher
      Member
      • Feb 2013
      • 23

      #3
      Thanks for the tip - but this does not seem to be the case. We are using relatively few reads and get FPKM=0 with "OK" and not "HIDATA".

      looking at IGV, it seems that in several of these cases the genes on the GF file overlap (this is a bacterial genome with high coding density). Could Cufflinks just skip these regions?

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Today, 12:17 PM
      0 responses
      10 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, Yesterday, 11:41 AM
      0 responses
      11 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      23 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      37 views
      0 reactions
      Last Post SEQadmin2  
      Working...